Usana Health Sciences files 10-Q without auditor review


According to the Securities and Exchange Commission rules, a public company is required to have an auditor review of quarterly financial statements prior to filing a 10-Q:

17 CFR Parts 210, 228, 229, and 240

[Release No. 34-42266; File No. S7-22-99]

RIN 3235-AH83

Audit Committee Disclosure

The Securities and Exchange Commission is adopting new rules and amendments to its current rules to require that companies’ independent auditors review the companies’ financial information prior to the companies filing their Quarterly Reports on Form 10-Q or Form 10-QSB with the Commission…

Usana admitted today in its 10-Q filing that it had not retained new auditors. That means this filing violates SEC rules.

Leave a Reply